Patient Guide: A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 27 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04875195
Status: COMPLETED
Condition: Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Phase: PHASE2

Find a Study Location Near You

This study is available at 27 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Torrance, California
  • New Orleans, Louisiana
  • Annapolis, Maryland
  • • And 24 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily